Edition:
India

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.50USD
18 Jul 2018
Change (% chg)

-- (--)
Prev Close
$1.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,678
52-wk High
$3.26
52-wk Low
$1.29

Chart for

About

Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology. The Company has generated various families of anticancer drugs that act on the cell cycle, including nucleoside analogs, cyclin dependent kinase (CDK) inhibitors, polo-like kinase (PLK) inhibitors and Aurora Kinase/vascular endothelial growth factor... (more)

Overall

Beta: 3.74
Market Cap(Mil.): $22.80
Shares Outstanding(Mil.): 11.40
Dividend: --
Yield (%): --

Financials

BRIEF-Cyclacel Pharmaceuticals Posts Qtrly Loss Of $2.1 Mln

* CYCLACEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

29 Mar 2018

Earnings vs. Estimates